TRANSFORMING OUTCOMES THROUGH NOVEL DIAGNOSTIC SOLUTIONS
Our platform offers a novel way to isolate nanoparticles directly from physiological solutions, such as whole blood, plasma or serum.
Our first assay will monitor treatment response in oncology
Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform Technology
Publications Michael Heller, cfDNA, mitochondria, hmw-DNA, Chronic Lymphocytic Leukemia (CLL), 2013 Biological Dynamics
Dielectrophoretic Isolation and Detection of cfc-DNA Nanoparticulate Biomarkers and Virus from Blood
WE ARE SOCIAL!